MediGene

MediGene

Official site for Medigene. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies..

Launch date
Employees
Market cap
€28.2m
Enterprise valuation
€17m (Public information from Sep 2024)
Company register number HRB 115761 (München)
Planegg Bavaria (HQ)
Authorizing premium user...